Related Experiment Videos
Genetic interactions between the coagulation and fibrinolytic systems
1Children's Hospital Research Foundation, Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA. degenjl@chmcc.org
Thrombosis and Haemostasis
|August 7, 2001
Summary
Transgenic mice with altered genes for blood clotting and fibrinolysis factors are advancing our understanding of hemostasis. Studies of these gene-targeted mice are refining concepts of hemostatic factor roles in vivo.
Area of Science:
- * Hemostasis and Thrombosis Research
- * Genetics and Molecular Biology
- * Mammalian Physiology
Background:
- * Established coagulation and fibrinolytic factors are crucial for hemostasis.
- * Understanding their in vivo roles requires precise genetic manipulation.
- * Transgenic mouse models offer powerful tools for studying these complex systems.
Purpose of the Study:
- * To review the generation and characterization of gene-targeted mice lacking key hemostatic factors.
- * To highlight new insights into the roles and interplay of coagulation and fibrinolytic factors.
- * To discuss how these models refine existing concepts of hemostasis.
Main Methods:
- * Generation of transgenic mice with altered or disrupted genes for hemostatic factors.
- * Phenotypic characterization of these gene-targeted mouse lines.
- * Analysis of mice with combined deficiencies in coagulation and fibrinolytic systems.
Main Results:
- * Nearly all genes for established coagulation and fibrinolytic factors have been modified in mice.
- * Initial findings have significantly refined understanding of hemostatic factor functions in vivo.
- * Studies of multiple hemostatic factor deficits reveal new insights into system interplay.
Conclusions:
- * Gene-targeted mouse models are essential for dissecting complex hemostatic pathways.
- * These models have already challenged and refined long-standing concepts in the field.
- * Further research with these models promises deeper understanding of hemostasis and thrombosis.